KDR and neoplasm: Many studies that were subsequently performed focused on the further elucidation of the tumor intrinsic or TME-related mechanisms of VEGFA regulation and release; clinical trials evaluating other anti-angiogenic factors drugs and development and testing studies to direct target VEGFR2 have also been pursued 48.